Concepedia
Statistics
Publications
2
Citations
92
H-Index
Active since
2010
Affiliations
Rutgers Cancer Institute(Current)
Johnson University
Kim T. Merrigan is an author at Rutgers Cancer Institute specializing in oncology, cell signaling, and signal transduction.
Publications per year
2010–2011
The Glutamate Release Inhibitor Riluzole Decreases Migration, Invasion, and Proliferation of Melanoma Cells
Maithao Le, Joseph L.‐K. Chan, Stephen A. Rosenberg et al. · Journal of Investigative Dermatology · 2010 · 65 citations · Full text
Life Sciences, Oncology, Pharmacology +12
Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor‐β‐mediated growth inhibition
Karine Cohen-Solal, Kim T. Merrigan, Joseph L.‐K. Chan et al. · Pigment Cell & Melanoma Research · 2011 · 27 citations
Life Sciences, Cell Biology, Oncology +15
1–2 of 2